Home > As Somozas

Antonio Delgado

Natac wins the SSIS 2013

Natac wins the Startup Competition in the Science & Biotech category! Antonio Delgado and José Carlos Quintela, Natac’s cofounders, attend a ceremony to receive the prize to Natac’s achievements from Their Royal Highnesses the Prince […]

Published on 25 of February 2025

Uncategorized

Natac participates in the Spain Startup & Investor Summit 2013

Natac participates in the Spain Startup & Investor Summit 2013 Startup & Investor Summit is a unique platform where the most innovative projects of Spanish entrepeneurs are presented to investors, companies and institutions. And Natac […]

Published on 25 of February 2025

Antonio Delgado

Natac in Diario Médico

Natac in Diario Médico Natac appears as a front-line research-based pharmaceutical company in Diario Médico. Alejandro Arranz, CEO of Parque Científico de Madrid, highlights the high professional profile of the companies hosted by PCM and […]

Published on 25 of February 2025

Interview

José Carlos Quintela for El Correo Farmacéutico

José Carlos Quintela for El Correo Farmacéutico Our CSO and co founder, José Carlos Quintela, is interviewed as President of the Committee on Food Supplements (COAL) of Anefp for El Correo Farmacéutico, one of the […]

Published on 25 of February 2025

4 articles

As Somozas

Order

As Somozas

The regional delegate of the Xunta de Galicia visits our omega-3 plant in As Somozas

The territorial delegate of the Xunta de Galicia in Ferrol, Martina Aneiros, has visited the omega-3 production plant that Natac has opened in As Somozas, the largest in Spain. She was accompanied by the […]

Published on 25 of February 2025

Antonio Delgado

Antonio Delgado, Natac’s CEO, in Radio Intereconomía: ‘There are few companies ready to sell to the pharmaceutical industry and Natac is one of them’

The program Capital Intereconomía of Radio Intereconomía has interviewed Antonio Delgado, Natac’s CEO, within its section ‘Listed companies’ to know the company’s trajectory and its latest achievements. Delgado has talked about Natac’s origins and […]

Published on 25 of February 2025

Antonio Delgado

Natac, in the top 15 companies by return in the Horizon Europe Programme

Natac Group (NAT), a biotech company specialising in the sustainable production of botanical extracts with proven health benefits, consolidates its position as a key player in innovation in Spain. The company ranks thirteenth nationally […]

Published on 25 of February 2025

Antonio Delgado

Natac certifies the omega-3 plant in As Somozas with the GMP+ and Halal seals

Natac Group (NAT), a biotechnology company specialised in the sustainable production of botanical extracts and omega-3 oils, has obtained the first two certifications for its omega-3 factory in As Somozas (Coruña), which was launched […]

Published on 14 of January 2025

Filter articles by year

DOWNLOAD

Press dossier

Download the pess dossier

By providing your contact information you will gain access to the selected content.

Fields marked with (*) are required

"*" indicates required fields

Name*

Surname(s)*

Email*

Telephone*

Company*

Company website

Country*

Which file do you want to download?*

Comments

Consent*

I have read and agree to the processing of my data in accordance with the Privacy Policy. We inform you that Grupo Natac, S.L.U. and its subsidiaries are responsible for the processing of your personal data, in order to keep you informed about our products and services and upcoming events that may be of interest to you, with your consent. You have the right to access, rectify and delete your data, as well as other rights, as explained in the additional information in our Privacy Policy. By clicking the "SEND" button, you declare that you understand and accept Natac's Privacy Policy.*

Subscribe to our Newsletter

Receive the latest news on Natac in your email

I have read and accept the processing of my data, in accordance with the provisions of . I agree to receive communications about Natac products, projects and events that may be of interest to me.